Tricuspid valve dysfunction (degree of regurgitation) - excluding patients with lead dependent TV dysfunction
Average tricuspid valve regurgitation [0-4 degree], mean ±SD
1.454±0.956
Patients with severe tricuspid regurgitation [3-4], n ( %) 162 (18.493)
Lead dependent tricuspid valve dysfunction (LDTD) Average LDTD [0-4], mean±SD 3,541±0.594
Patients with LDTD (any), n ( %) 60 (6.410)
Patients with severe LDTD [3-4,] n ( %) 58 (96.667)
Any shadows on the leads Patients with any shadows on leads before TLE, n (%) 607 (64.850)
Patients with fibrous tissue binding the lead to the vena cava superior and heart structures, n (%) Patients with fibrous tissue binding the lead to the vena cava superior and heart structures, n (%) 236 (25.214)
Fibrous tissue binding the lead to the vena cava superior and heart structures Fibrous tissue binding the lead to the heart structures (all), n (%)
316 (33.761)
Fibrous tissue binding the lead to the SVC, n (%) 56 (5.983)
Fibrous tissue binding the lead to the RA wall, n (%) 65 (6.944)
Fibrous tissue binding the lead to the tricuspid apparatus, n (%)
90 (9.615)
Fibrous tissue binding the lead to the RV wall, n (%) 105 (11.218)
Fibrous tissue binding two leads, n (%) Fibrous tissue binding two leads, n (%) 172 (18.377)
Patients with asymptomatic masses on endocardial leads (AMEL) (patient analysis), n (%) Patients with asymptomatic masses on endocardial leads (AMEL) (patient analysis), n (%) 437 (46.688)
AMEL (findings analysis) AMEL (all), n (%) 549 (58.654)
Fibrous tissue encasing the lead, n ( % of all ILM / % of all pts) 160 (29,144 / 17.094)
Lead thickening, n ( % of all ILM / % of all pts)
277 (50,455 / 29.594)
Clot on the lead, n (% of all ILM / % of all pts)
75 (13,661 / 8.013)
Vegetation-like masses, n ( % of all ILM / % of all pts)
37 (6,740 / 3.953)
Presence of vegetations Patients with vegetations, n (%) 119 (12.727)
Excess lead loops in the heart Patients with lead loops in the heart (any), n (%) 181 (19.338)
Lead loops in the RA n (%) 138 (14.744)
Lead loops in the TV, n (%) 35 (3.793)
Lead loops in the RV or PA, n (%) 28 (2.991)
Perforation or penetration of the lead through the cardiac wall up to the epicardium Perforations, n (%) 151 (16.132)